股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 醫渡科技有限公司 呈交日期: 2025年11月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02158 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,500,000,000 | USD | | 0.00002 USD | | 50,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | 2,500,000,000 | USD | | 0.00002 USD | | 50,000 | 第 2 頁 共 10 頁 v 1.1.1 III.已發行股份及/或庫存股份變動詳情 本月底法 ...

Group 1 - The "Sui Sui Kang" supplementary health insurance program in Guangzhou has opened for enrollment for the 2026 fiscal year, with over 2 million participants on the first day [1] - The program, initiated in December 2020, allows for insurance coverage without age or pre-existing condition restrictions, and offers reimbursement for self-paid medications without disease or drug type limitations [1] - The annual premium remains at 180 yuan, providing coverage up to 2.45 million yuan, including hospitalization, outpatient services, and more [1] Group 2 - The first five-year pilot of "Sui Sui Kang" has been successfully completed, with stable enrollment between 3.53 million and 3.84 million participants from 2021 to 2025, and an annual renewal rate exceeding 80% [3] - Over the five years, the program has provided coverage for 18.28 million instances, with 880,000 claims totaling 2.57 billion yuan, reducing the financial burden of medical expenses by 37.8% for claimants [3] - In 2026, the program will introduce a subsidy of 200 to 400 yuan for eligible insured individuals, enhancing participant satisfaction [3] Group 3 - Yidu Technology, a leader in AI healthcare, has developed the "AI Medical Brain" YiduCore, which offers comprehensive solutions for urban insurance programs, including product design, system setup, and intelligent claims processing [4] - The company has participated in the development and operation of "benefit insurance" projects across 5 provinces and 13 cities, serving over 40 million insured users [4] - Yidu Technology aims to leverage its technological expertise and operational capabilities to enhance the smart and inclusive service experience of the "Sui Sui Kang" program for Guangzhou residents [4]

Group 1 - The core viewpoint of the report indicates that the "14th Five-Year Plan" released by the 20th National Congress exceeds market expectations, alongside signs of easing US-China relations and strengthened expectations for US Federal Reserve interest rate cuts, which will support the Hong Kong stock market's transition from "suppressed" to "rising" in the fourth quarter [1] - As of October 24, southbound funds have accumulated holdings of 241 million shares in Hong Kong stocks, with a total market value of 1.368 billion HKD, representing a holding ratio of 22.48% [2] Group 2 - Medtronic Technology (2158.HK), an "AI + healthcare" company, has gained significant attention from southbound funds, with net purchases of 609,200 shares on October 24, amounting to a net buy of 3.4663 million HKD, marking 11 consecutive days of net buying and a total net purchase exceeding 100 million HKD [1] - Over the past 30 trading days, southbound funds have cumulatively net bought 14.4 million HKD of Medtronic Technology [1]

Core Viewpoint - Multiple companies, including China Feihe and Lianyi Rong Technology, conducted share buybacks on October 24, 2025, with China Feihe leading in both the number of shares repurchased and the total amount spent [1][2]. Group 1: Buyback Details - China Feihe (06186) repurchased 5.885 million shares for a total of 23.6977 million yuan, representing 0.087% of its total share capital [2]. - Lianyi Rong Technology (09959) repurchased 2.4 million shares for 7.3782 million yuan, accounting for 3.516% of its total share capital [2]. - Beike-W (02423) repurchased 1.1784 million shares for 7 million yuan, which is 1.722% of its total share capital [2]. Group 2: Other Notable Buybacks - Yum China (09987) repurchased 17,800 shares for 6.2549 million yuan, representing 2.830% of its total share capital [2]. - Mengniu Dairy (02319) repurchased 400,000 shares for 5.7447 million yuan, which is 0.545% of its total share capital [2]. - Kangsong Pharmaceutical (01681) repurchased 100,000 shares for 1.5180 million yuan, accounting for 8.582% of its total share capital [2].

Core Viewpoint - The company, Yidu Tech (02158), has been actively repurchasing its shares, indicating management's confidence in the stock's future appreciation potential [1] Group 1: Share Buyback Activity - On October 24, Yidu Tech repurchased approximately 21,200 shares for about 120,000 HKD in a single day [1] - The company has completed 10 share buybacks since September 26, totaling over 3.88 million ordinary shares and nearly 22.5 million HKD in total repurchase amount [1] Group 2: Total Return Swap Transaction - Yidu Tech announced a total return swap transaction with a nominal capital amount of approximately 54.4 million HKD, with Goldman Sachs as the counterparty, for a duration of about 3 years [1] - The purpose of this transaction is to hedge against the risk of future stock price appreciation, thereby reducing costs and cash flow risks associated with share purchases [1] Group 3: Market Sentiment and Stock Performance - Analysts believe that the signing of the total return swap indicates management's optimistic outlook on the company's future stock price appreciation [1] - As of October 24, Yidu Tech's stock price closed at 5.74 HKD, reflecting a 2.87% increase [2]

Core Viewpoint - The company, Yidu Tech (02158), has been actively repurchasing its shares, indicating management's confidence in the stock's future appreciation potential [1][2]. Group 1: Share Repurchase Activity - On October 24, Yidu Tech repurchased approximately 21,200 shares for about HKD 120,000 [1]. - The company has completed 10 repurchase transactions since September 26, totaling over 3.88 million ordinary shares and nearly HKD 22.5 million in total repurchase amount [1]. Group 2: Total Return Swap Transaction - On October 23, Yidu Tech announced a total return swap transaction with a nominal capital amount of approximately HKD 54.4 million, with Goldman Sachs as the counterparty [1]. - The transaction is set for a duration of about three years and aims to hedge against the risk of future stock price appreciation [1]. Group 3: Management's Perspective - Analysts interpret the signing of the total return swap as a sign of management's optimistic outlook on the company's future stock price [1]. - The strategy of acquiring shares at a low point to mitigate the risk of increased costs due to stock price appreciation reflects the company's proactive risk management approach [1].

Core Viewpoint - The company, Yidu Tech (02158.HK), announced a share buyback on October 24, 2023, spending HKD 120,000 to repurchase 21,000 shares [1] Group 1 - The total expenditure for the share buyback was HKD 120,000 [1] - The number of shares repurchased in this transaction was 21,000 [1]

FF305 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | | | | 於下列日期開始時的結存(註1) | 2025年10月23日 | | 1,063,870,7 ...

Core Viewpoint - The announcement by Yidu Tech (02158) regarding a total return swap transaction with Goldman Sachs indicates a strategic move to hedge against future stock price appreciation risks, reflecting management's optimistic outlook on the company's valuation potential [1] Group 1: Total Return Swap Transaction - Yidu Tech's subsidiary entered into a total return swap transaction with a nominal equity amount of HKD 54.4047 million, with a duration of approximately three years [1] - The purpose of this transaction is to mitigate the risk of stock price appreciation, particularly in relation to the potential costs and cash flow impacts associated with a share incentive plan post-IPO [1] Group 2: Stock Buyback and Valuation - Yidu Tech has been actively repurchasing shares, having bought back over 3.86 million ordinary shares at a total cost exceeding HKD 22 million since September 26 [1] - Analysts believe that the company's stock is significantly undervalued based on price-to-book ratios and the latest valuations of its international business and key asset reserves, excluding conservative estimates of domestic operations [1] Group 3: Management's Optimistic Outlook - The decision to enter into the total return swap transaction suggests that the management is optimistic about the company's future stock price appreciation potential [1] - By acquiring shares at a low point, the company aims to hedge against the risk of increased costs due to stock price appreciation, demonstrating a proactive risk management strategy [1]

Core Viewpoint - The announcement by Yidu Tech (02158) regarding a total return swap transaction with Goldman Sachs indicates a strategic move to hedge against future stock price appreciation risks, reflecting management's optimistic outlook on the company's valuation potential [1] Group 1: Total Return Swap Transaction - Yidu Tech's subsidiary entered into a total return swap transaction with a notional amount of HKD 54.4047 million, with a duration of approximately three years [1] - The purpose of the transaction is to hedge against the risk of stock price appreciation, particularly in relation to the potential price increase associated with the stock incentive plan post-IPO [1] Group 2: Stock Buyback and Valuation - Yidu Tech has been actively repurchasing shares, having bought back over 3.86 million ordinary shares at a total cost exceeding HKD 22 million since September 26 [1] - Analysts believe that the company's stock is significantly undervalued based on price-to-book ratios and the latest valuations of its international business and key asset reserves, excluding conservative estimates of domestic operations [1] Group 3: Management's Optimistic Outlook - The decision to enter into the total return swap transaction suggests that the management is optimistic about the company's future stock price appreciation potential [1] - By acquiring shares at a low point, the company aims to mitigate the risk of increased costs due to stock price appreciation, showcasing a proactive risk management strategy [1]